ImmuPharma plc (LON:IMM – Get Free Report)’s share price shot up 12.5% during mid-day trading on Friday . The stock traded as high as GBX 4.50 ($0.06) and last traded at GBX 4.05 ($0.05). 17,956,908 shares changed hands during mid-day trading, a decline of 5% from the average session volume of 18,883,104 shares. The stock had previously closed at GBX 3.60 ($0.04).
ImmuPharma Trading Up 10.5 %
The company has a market cap of £16.57 million, a P/E ratio of -397.90 and a beta of 1.53. The business’s 50 day simple moving average is GBX 1.71 and its 200 day simple moving average is GBX 1.72.
ImmuPharma Company Profile
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Further Reading
- Five stocks we like better than ImmuPharma
- Investing in the High PE Growth Stocks
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Expert Stock Trading Psychology Tips
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
